Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed) - Trial 2015-000607-15
Access comprehensive clinical trial information for 2015-000607-15 through Pure Global AI's free database. This Phase 3 trial is sponsored by Pfizer Inc and is currently status unknown. The study focuses on Bipolar Disorder.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2015-000607-15
Phase 3
Trial Details
EU Clinical Trials Register • 2015-000607-15
Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
Study Focus
Sponsor & Location
Pfizer Inc
Timeline & Enrollment
Phase 3
N/A
N/A
Primary Outcome
- Young Mania Rating Scale (YMRS) Total Score Change From Baseline
ICD-10 Classifications
Bipolar affective disorder
Bipolar affective disorder, unspecified
Other bipolar affective disorders
Bipolar affective disorder, currently in remission
Bipolar affective disorder, current episode mixed
Data Source
EU Clinical Trials Register
2015-000607-15
Non-Device Trial